[ALPHA-METHYL-(2R)-ASPARTYL]-BETA-(2S)-PHENYLALANYL-BETA-ALANYL-[ALPHA-METHYL-(2R)-GLUTAMYL]-GAMMA-GLYCINE-DIESTER
Compound with spectra: 1 NMR
![[ALPHA-METHYL-(2R)-ASPARTYL]-BETA-(2S)-PHENYLALANYL-BETA-ALANYL-[ALPHA-METHYL-(2R)-GLUTAMYL]-GAMMA-GLYCINE-DIESTER](/api/compound/AlnAQt8Ezxl.png?ph=true&h=300&w=458 "[ALPHA-METHYL-(2R)-ASPARTYL]-BETA-(2S)-PHENYLALANYL-BETA-ALANYL-[ALPHA-METHYL-(2R)-GLUTAMYL]-GAMMA-GLYCINE-DIESTER")
| SpectraBase Compound ID | AlnAQt8Ezxl |
|---|---|
| InChI | InChI=1S/C25H35N5O10/c1-39-24(37)16(26)13-21(33)30-18(12-15-6-4-3-5-7-15)23(36)27-11-10-20(32)29-17(25(38)40-2)8-9-19(31)28-14-22(34)35/h3-7,16-18H,8-14,26H2,1-2H3,(H,27,36)(H,28,31)(H,29,32)(H,30,33)(H,34,35)/t16-,17-,18+/m1/s1 |
| InChIKey | UTZKFZKECFHLLF-KURKYZTESA-N |
| Mol Weight | 565.6 g/mol |
| Molecular Formula | C25H35N5O10 |
| Exact Mass | 565.238392 g/mol |
| Enantiomer InChIKey | UTZKFZKECFHLLF-OKZBNKHCSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | D2O |
METHYL-N-(BENZYLOXYCARBONYL)-BETA-ALANYLPHENYLALANYLPHENYLALANINE
BENZYL-[(2R)-N-(TERT.-BUTOXYCARBONYL)-ALPHA-METHYLASPARTYL]-BETA-(2S)-PHENYLALANINATE-DIESTER
TERT.-BUTYL-[(2R)-N-BENZYLOXYCARBONYL-ALPHA-METHYL-ASPARTYL]-BETA-(2S)-PHENYLALANINATE-DIESTER
METHYL-N-(BENZYLOXYCARBONYL)-GLYCYLPHENYLALANYLPHENYLALANINE
ETHYL-N-(BENZYLOXYCARBONYL)-GLYCYLPHENYLALANYLPHENYLALANYLGLYCINE
ETHYL-N-(BENZYLOXYCARBONYL)-GLYCYLPHENYLALANYLPHENYLALANYLGLYCYLGLYCINE
METHYL-N-(BENZYLOXYCARBONYL)-ALANYLPHENYLALANYLPHENYLALANINE
LYS-ORN-PHE-ORN
LYS-PHE-PHE-ORN
METHYL-N-(BENZYLOXYCARBONYL)-ALANYLPHENYLALANYLPHENYLALANYLALANINE
| Title | Journal or Book | Year |
|---|---|---|
| Design and preparation of serine–threonine protein phosphatase inhibitors based upon the nodularin and microcystin toxin structures: Part 1. Evaluation of key inhibitory features and synthesis of a rationally stripped-down nodularin macrocycle | Journal of the Chemical Society, Perkin Transactions 1 | 1997 |